TrialNature communications2022

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.

Daniel Mrak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.